Save the date for our symposia in Mexico, co-hosted by CTR Scientific!
Our one-day event brought together experts from the pharmaceutical industry and regulatory bodies to support Mexico’s alignment with international best practices.
This event took place in two locations:
• 22th July 2025 – Ciudad de México (BelAir Unique a Wyndham Hotel)
• 24th July 2025 – Guadalajara (Hotel Diana Plaza)
Agenda highlights included ICH M7, acceptable intake setting for NDSRIs, risk mitigation strategies, real-world case studies and more!
Session 1 – Classifying Impurities Under ICH M7: Expert Insights
- Lucía Toscano, Lhasa Limited
- Dr David Ponting, Lhasa Limited
Session 2– Strategies for Potentially Mutagenic Impurity Formation and Control
- Dr María Celeste Del Fueyo, Lhasa Limited
- Dr Andrew Teasdale, Former AstraZeneca
Session 3 – Nitrosamine Risk Assessment: Industry and Regulatory Perspectives
- Dr Naomi Kruhlak, US FDA
- Melina Dal Mas, ANMAT Salud
- Dr Mariah Ultramari, Spektra Consultoria
Session 4 – Degradation, Compatibility and Strategies on Impurities Assessment
- Mary Carmen Del Moral Hernández, Laboratorios Carnot
- Diego Gomes, Lhasa Limited
- Dr Natanael Segretti, Spektra Consultoria